Prof. Andreas Plueckthun | Professor of Biochemistry, Director, Department of Biochemistry
University of Zurich, Dept. of Biochemistry

Prof. Andreas Plueckthun, Professor of Biochemistry, Director, Department of Biochemistry, University of Zurich, Dept. of Biochemistry

Andreas Plückthun has been Professor of Biochemistry at the University of Zürich, Switzerland since 1993. He studied chemistry at the University of Heidelberg and received a PhD from the University of California at San Diego in 1982, was postdoctoral fellow at Harvard University (1982-85), and group leader at the Genzentrum and Max-Planck-Institut für Biochemie in Martinsried (1985-93). He has written over 400 publications, cited over 35,000 times (h-index 109). He was elected to the German Academy of Science in 2003.
He received numerous international awards, among them the 2016 Christian-Anfinsen Award of the Protein Society as "pioneer of protein engineering". He is co-founder of Morphosys AG (Martinsried, Germany), Molecular Partners AG (Zürich, Switzerland) and G7 Therapeutics, recently divested to Heptares/Sosei (Zürich, Switzerland).
His research field is protein engineering in all flavors: antibodies, novel scaffold proteins (DARPins and Armadillos), and stable membrane proteins. His laboratory combines biophysical studies, directed evolution and biomedical applications.

Appearances:



EAC 2017 Day 1, Tuesday 31st October 2017 @ 17:10

Panel: Antibody nomenclature and INN strategies

  • Panel to discuss the current confusion surrounding antibody nomenclature
  • Why does the naming system have to be changed?
  • What problems are these causing in the clinic and the lab?
  • Suggestions on how this system can be improved
 

back to speakers